Anti-Mullerian Hormone and conception timing as predictors of live births in cancer patients using fertility preservation: a systematic review
{{output}}
Objectives: Among women of childbearing potential aged 15-39, cancer incidence is 52.3 per 100,000 annually. Women newly diagnosed with cancer often have just 2-6 weeks to decide whether to pursue fertility preservation (FP) befo... ...
